Tag: Thomas Lingelbach
Valneva’s dead vaccine shows good data – approval could take place in 2022
Frankfurt The French vaccine developer Valneva is raising new hopes for a possible approval of its vaccine with positive data for its Covid vaccine. According to initial results from a…